Literature DB >> 21506130

Role of GLI2 in the growth of human osteosarcoma.

Hiroko Nagao1, Kosei Ijiri, Masataka Hirotsu, Yasuhiro Ishidou, Takuya Yamamoto, Satoshi Nagano, Takumi Takizawa, Kinichi Nakashima, Setsuro Komiya, Takao Setoguchi.   

Abstract

The Hedgehog pathway functions as an organizer in embryonic development. Aberrant activation of the Hedgehog pathway has been reported in various types of malignant tumours. The GLI2 transcription factor is a key mediator of Hedgehog pathway but its contribution to neoplasia is poorly understood. To establish the role of GLI2 in osteosarcoma, we examined its expression by real-time PCR using biopsy tissues. To examine the function of GLI2, we evaluated the growth of osteosarcoma cells and their cell cycle after GLI2 knockdown. To study the effect of GLI2 activation, we examined mesenchymal stem cell growth and the cell cycle after forced expression of GLI2. We found that GLI2 was aberrantly over-expressed in human osteosarcoma biopsy specimens. GLI2 knockdown by RNA interferences prevented osteosarcoma growth and anchorage-independent growth. Knockdown of GLI2 promoted the arrest of osteosarcoma cells in G(1) phase and was accompanied by reduced protein expression of the cell cycle accelerators cyclin D1, SKP2 and phosphorylated Rb. On the other hand, knockdown of GLI2 increased the expression of p21(cip1) . In addition, over-expression of GLI2 promoted mesenchymal stem cell proliferation and accelerated their cell cycle progression. Finally, evaluation of mouse xenograft models showed that GLI2 knockdown inhibited the growth of osteosarcoma in nude mice. Our findings suggest that inhibition of GLI2 may represent an effective therapeutic approach for patients with osteosarcoma.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506130     DOI: 10.1002/path.2880

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

1.  S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.

Authors:  Lu Ding; Rong Li; Rongxin Sun; Yang Zhou; Yubo Zhou; Xiaoping Han; Yong Cui; Wu Wang; Qing Lv; Jingping Bai
Journal:  Cell Cycle       Date:  2017-08-03       Impact factor: 4.534

2.  miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2.

Authors:  Zhengwen Sun; Tongqing Zhang; Huanyu Hong; Qingxia Liu; Haiguang Zhang
Journal:  Mol Cell Biochem       Date:  2014-08-26       Impact factor: 3.396

3.  Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.

Authors:  Yimin Ma; Yongxin Ren; Ethan Q Han; Huiwu Li; Di Chen; Joshua J Jacobs; Steven Gitelis; Regis J O'Keefe; Yrjö T Konttinen; Guoyong Yin; Tian-Fang Li
Journal:  Biochem Biophys Res Commun       Date:  2013-01-03       Impact factor: 3.575

4.  Hedgehog signaling pathway and ovarian cancer.

Authors:  Qi Chen; Guolan Gao; Shiwen Luo
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

5.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.

Authors:  Rafael Kramann; Susanne V Fleig; Rebekka K Schneider; Steven L Fabian; Derek P DiRocco; Omar Maarouf; Janewit Wongboonsin; Yoichiro Ikeda; Dirk Heckl; Steven L Chang; Helmut G Rennke; Sushrut S Waikar; Benjamin D Humphreys
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

6.  Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.

Authors:  Fenyong Chen; Jiadong Mo; Li Zhang
Journal:  Tumour Biol       Date:  2016-07-27

7.  Sonic Hedgehog Signaling Affected by Promoter Hypermethylation Induces Aberrant Gli2 Expression in Spina Bifida.

Authors:  Xiao-Lin Lu; Li Wang; Shao-Yan Chang; Shao-Fang Shangguan; Zhen Wang; Li-Hua Wu; Ji-Zhen Zou; Ping Xiao; Rui Li; Yi-Hua Bao; Z-Y Qiu; Ting Zhang
Journal:  Mol Neurobiol       Date:  2015-10-07       Impact factor: 5.590

8.  Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.

Authors:  Seisuke Tanigawa; Mitsugu Fujita; Chiami Moyama; Shota Ando; Hiromi Ii; Yasushi Kojima; Teruaki Fujishita; Masahiro Aoki; Hayato Takeuchi; Takumi Yamanaka; Yoshinobu Takahashi; Naoya Hashimoto; Susumu Nakata
Journal:  Cancer Gene Ther       Date:  2021-01-07       Impact factor: 5.987

9.  Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.

Authors:  Kanya Honoki; Hiromasa Fujii; Yasuaki Tohma; Toshifumi Tsujiuchi; Akira Kido; Shinji Tsukamoto; Toshio Mori; Yasuhito Tanaka
Journal:  ISRN Oncol       Date:  2012-07-17

10.  Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma.

Authors:  Christophe Paget; Helene Duret; Shin Foong Ngiow; Maya Kansara; David M Thomas; Mark J Smyth
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.